# Clovis Oncology Inc. (CLVS)

Source: https://www.quantisnow.com/company/CLVS
Generated: 2026-11-13T10:29:10.055Z

- Ticker: CLVS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2011
- Website: clovisoncology.com

## About

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, the European Union, and internationally. The company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. It also provides lucitanib, an investigational angiogenesis inhibitor, which inhibits vascular endothelial growth factor receptors 1 through 3 (VEGFR 1-3), platelet-derived growth factor receptors alpha and beta (PDGFRa/ß), and fibroblast growth factor receptors 1 through 3 (FGFR 1-3); and FAP-2286, a peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein. The company distributes its products primarily through specialty pharmacies and distributors to patients and health care providers. Clovis Oncology, Inc. has license agreements with Pfizer Inc., AstraZeneca UK Limited, Advenchen Laboratories LLC, and 3B Pharmaceuticals GmbH, and Bristol Myers Squibb Company; and a partnership with Foundation Medicine, Inc. The company was incorporated in 2009 and is headquartered in Boulder, Colorado.

## Latest CLVS news and filings

- 2023-07-18 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-clovis-oncology-inc-4763171)
- 2023-07-11 16:09 UTC [SEC Form 15-12G filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-clovis-oncology-inc-4741334)
- 2023-07-11 16:05 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clovis-oncology-inc-4741315)
- 2023-07-11 16:00 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clovis-oncology-inc-4741287)
- 2023-07-11 15:56 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clovis-oncology-inc-4741233)
- 2023-07-11 15:55 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clovis-oncology-inc-4741227)
- 2023-07-11 15:54 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clovis-oncology-inc-4741221)
- 2023-07-11 15:52 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clovis-oncology-inc-4741212)
- 2023-07-11 15:51 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clovis-oncology-inc-4741207)
- 2023-07-11 15:51 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clovis-oncology-inc-4741204)
- 2023-07-11 15:50 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clovis-oncology-inc-4741199)
- 2023-07-11 15:50 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clovis-oncology-inc-4741197)
- 2023-07-11 15:48 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clovis-oncology-inc-4741192)
- 2023-07-11 15:43 UTC [SEC Form POS AM filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-clovis-oncology-inc-4741165)
- 2023-07-11 13:37 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-bankruptcy-or-receivership-4740323)
- 2023-06-30 21:08 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-material-modification-to-4711289)
- 2023-06-02 21:00 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-regulation-fd-disclosure-4597950)
- 2023-05-03 12:53 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-regulation-fd-disclosure-4434431)
- 2023-05-01 20:16 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-completion-of-acquisition-4421102)
- 2023-04-14 12:01 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-completion-of-acquisition-4335624)
- 2023-04-06 20:16 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-entry-into-a-4310143)
- 2023-03-31 10:05 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-regulation-fd-disclosure-4276410)
- 2023-03-02 13:00 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-regulation-fd-disclosure-4150139)
- 2023-02-16 21:32 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-leadership-update-4079157)
- 2023-02-10 14:48 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Clovis Oncology Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-clovis-oncology-inc-amendment-4038155)
- 2023-01-11 23:12 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-entry-into-a-3903362)
- 2022-12-29 14:35 UTC [SEC Form 25-NSE filed by Clovis Oncology Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-clovis-oncology-inc-3853281)
- 2022-12-22 09:37 UTC [FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC](https://www.quantisnow.com/insight/fda-approval-for-rubraca-issued-to-clovis-oncology-inc-3835528)
- 2022-12-19 22:02 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-creation-of-a-3824174)
- 2022-12-15 16:19 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Thursday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-thursday-3811459)
- 2022-12-14 21:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-after-market-session-3807304)
- 2022-12-14 19:20 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Wednesday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-wednesday-3806372)
- 2022-12-14 11:30 UTC [Market Insight] [Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-vallon-pharmaceuticals-shares-are-trading-higher-by-over-150-3803433)
- 2022-12-13 17:38 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Tuesday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-tuesday-3800501)
- 2022-12-13 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-intraday-session-3800461)
- 2022-12-13 17:14 UTC [Market Insight] [Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-opgen-shares-are-trading-higher-by-220-here-are-3800378)
- 2022-12-13 11:09 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-notice-of-delisting-3797444)
- 2022-12-13 11:07 UTC [SEC Form 8-K] [Clovis Oncology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation, Events That Accelerate or Increase a Direct Financial Obligation, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clovis-oncology-inc-filed-sec-form-8-k-entry-into-a-3797433)
- 2022-12-12 15:50 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Monday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-monday-3794187)
- 2022-12-12 12:29 UTC [Market Insight] [Cancer Focused Clovis Oncology Files For Bankruptcy](https://www.quantisnow.com/insight/cancer-focused-clovis-oncology-files-for-bankruptcy-3792383)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CLVS
- Earnings history: https://www.quantisnow.com/earnings/CLVS
- Dividend history: https://www.quantisnow.com/dividends/CLVS
- Insider transactions: https://www.quantisnow.com/insiders/CLVS
- Options chain: https://www.quantisnow.com/options/CLVS
- SEC 8-K filings only: https://www.quantisnow.com/company/CLVS/8-k
- RSS and alerts for CLVS: https://www.quantisnow.com/docs/rss-feeds.md